JPMorgan Resumes Actavis (ACT) at Overweight
Tweet Send to a Friend
JPMorgan resumed coverage on Actavis (NYSE: ACT) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
